The aim of this study was to systematically review the range, nature, and extent of current research activity exploring the influence of innovative health-related technologies on social inequalities in health, with specific focus on a deeper understanding of the variables used to measure this connection and the pathways leading to the (re)production of inequalities. A review process was conducted, based on scoping review techniques, searching literature published from January 1, 1996 to November 25, 2016 using MEDLINE, Scopus, and ISI web of science. Search, sorting, and data extraction processes were conducted by a team of researchers and experts using a dynamic, reflexive examination process. Of 4139 studies collected from the search process, a total of 33 were included in the final analysis. Results of this study include the classification of technologies based on how these technologies are accessed and used by end users. In addition to the factors and mechanisms that influence unequal access to technologies, the results of this study highlight the importance of variations in use that importantly shape social inequalities in health. Additionally, focus on health care services technologies must be accompanied by investigating emerging technologies influencing healthy lifestyle, genomics, and personalized devices in health. Findings also suggest that choosing one measure of social position over another has important implications for the interpretation of research results. Furthermore, understanding the pathways through which various innovative health technologies reduce or (re)produce social inequalities in health is context dependent. In order to better understand social inequalities in health, these contextual variations draw attention to the need for critical distinctions between technologies based on how these various technologies are accessed and used. The results of this study provide a comprehensive starting point for future research to further investigate how innovative technologies may influence the unequal distribution of health as a human right.
Citation: Weiss D, Rydland HT, Øversveen E, Jensen MR, Solhaug S, Krokstad S (2018) Innovative technologies and social inequalities in health: A scoping review of the literature. PLoS ONE 13(4): e0195447. https://doi.org/10.1371/journal.pone.0195447
Editor: Gianni Virgili, Universita degli Studi di Firenze, ITALY
Received: October 3, 2017; Accepted: March 22, 2018; Published: April 3, 2018
Copyright: © 2018 Weiss et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All studies and available data included in this review are made available as a supporting file (S1 File.txt) or included in the main text of this manuscript.
Funding: This research received funding from the strategic research area NTNU Health in 2016/17 at NTNU, Norwegian University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Despite expectations to the contrary, social inequalities in health appear to be increasing in many of the world’s most developed countries during an era of rapid innovative technological development [1–3]. As the quantification of health in modern society intensifies and innovative health technologies become the cornerstone of this transition, the connection between technology and health is garnering increased attention [4–7]. Recent years have witnessed an era of intensified technology use in health care services  as well as developments in personalized medicine and the use of big data for health purposes. These advances have promoted a growing dependency on technology in society and the collection of advanced information, including that of the personal genome, which are then used to influence the decisions and behaviors of not just ordinary citizens but also health personnel, private companies, and large institutions [9–11]. These innovations are generally seen as positive developments, improving the diagnostics and treatment of disease as well as general public health, however their wider societal implications can be questioned [10, 12–14]. It appears likely that these technologies could be improving general public health but at the cost of increasing inequalities in health [13, 15].
Various publications have addressed the importance of further investigating the potential implications that the rapid development and increased prioritization of various technological innovations in health have on the health of society as a whole [3, 10–12, 16, 17]. Other studies have empirically investigated the production of inequalities in health due to the advent of innovative technologies [18–20]. These studies demonstrate that individuals of higher socioeconomic status (SES) are the first to adopt, and benefit most from, the introduction of innovative technologies in health, creating social inequalities in health where they were once very low or nonexistent, or in some cases even inverting these inequalities (where improved health outcomes have moved from lower SES groups to higher SES groups). This phenomenon is further illustrated by results demonstrating larger social inequalities in health among populations suffering from illnesses for which effective preventive or treatment techniques have been developed . These studies provide a starting point for investigating additional mechanisms that may explain the (re)production of social inequalities in health [22, 23]. As the rate of innovative health technology intensifies, a better understanding of this perspective is becoming increasingly important.
Still missing from the literature is a broad foundation from which to further investigate and explain the connection between technological innovations and social inequalities in health. The following questions are still in need of clarification:
- How are innovative health technologies defined in a social inequalities context?
- What are the implications of using various measurements of social inequality?
- How do existing studies explain the potential relationship between innovative health technology and social inequalities in health?
- How may innovative health technologies reduce or (re)produce social inequalities in health?
The aim of this study, therefore, was to systematically review the range, nature, and extent of current research activity exploring the influence of innovative health technologies on social inequalities in health, with specific focus on a deeper understanding of the variables used to measure this connection and the pathways leading to its (re)production.
A systematic search process was conducted, based on scoping review techniques, [24, 25] for literature published from January 1, 1996 to November 25, 2016 using the following databases: MEDLINE, Scopus, and ISI web of science. The search was updated on November 25, 2016. Scoping review methods were used for their ability to explore broad research questions and interpret large amounts of material from various forms of data and research, while providing an important first step in synthesizing a complex body of research that can be used to guide the direction of future research [26, 27].
Search terms were categorized into four categories (“public health,” “social inequality,” “technology and innovation,” “theoretical foundation”) in order to provide additional organization when combining terms during the search process (Fig 1). Only peer-reviewed studies based on original data analysis were included in this study, as interest was focused on collecting empirical analyses. A full overview of inclusion/exclusion criteria can be found in Table 1.
The initial search process was performed by two research librarians with expertise in the use of literature databases. Extensive testing of the search strings was performed before the search process. To reduce the number of irrelevant hits and increase accuracy of the searches, a proximity operator was used as well as custom search strings for each database. Rationale and search strings for each individual database can be found in Table 2.
The initial search resulted in a total of 4139 studies, after cleaning of the original data file. After sorting the dataset alphabetically by study title, the entire dataset was divided into four equal subsets. Each subset was then sorted independently by two individual researchers. Studies deemed relevant by both researchers automatically advanced to secondary sorting. A third researcher, who had not previously worked with the respective subset, then sorted those studies deemed relevant by only one of the two original researchers. Studies deemed relevant by the third researcher also advanced to secondary screening. All relevant studies from the initial screening process were then combined into a single dataset (465 studies) for use during the secondary screening process. During the secondary screening process, three individual researchers independently sorted all studies deemed relevant from the initial sorting process using abstracts (if abstracts were not present, results and conclusion sections were used to determine relevance). Only studies deemed relevant by all three researchers advanced to the final sorting process. In the final sorting process, three individual researchers independently read full texts of all included studies. Studies deemed relevant by all three researchers automatically advanced to the data extraction process, while studies deemed irrelevant by all three researchers were automatically excluded. Studies with inconsistent evaluations were discussed by all three researchers until agreement for inclusion or exclusion was met. The resultant studies from this multi-stage systematic sorting process were included in the data extraction process and presented in our results section (Fig 2). The inclusion/exclusion criteria was strictly applied at each stage of the sorting process and articles were excluded if deemed by multiple researchers to meet exclusion criteria based on title and keywords (stage 1), abstracts (stage 2), or full text (stage 3).
Data extraction was facilitated by the use of a data extraction form designed using procedures outlined by Armstrong et al. . A data extraction form was used to systematically extract information relevant to the aims of this study as well as standard descriptive information. Along with standard title, author and year of publication information, categories included: study location; geographical level (local, regional, national or international); study population; methods used; specific illness addressed; technological innovation addressed/measured; method of implementation for the addressed technology; definition/measurement of social class/inequality; theoretical perspectives; main outcome measures (including health outcomes); overview of main results and conclusions. All full texts were read and analyzed by three individual researchers and individual data extraction forms were then merged into a single, unifying document used for the interpretation and presentation of results. Following typical scoping review methods, methodological quality of the included articles was not assessed systematically, however only peer-reviewed articles were included in our review process [24, 25, 28]. The lack of a systematic analysis of methodological quality is both a weakness and a strength of scoping review techniques. Although it is difficult for a scoping review to draw conclusions based on the quality of the included studies, the strength of a scoping review is in its ability to condense large amounts of material and guide the direction of future research including more comprehensive analyses of the quality of relevant methods [27, 28]. Assurance of methodological quality throughout the search, sorting and extraction processes in the current study however was protected using a systematic design based on a dynamic, reflexive examination process whereby multiple researchers, working at each stage of the process independently, regularly compared results and met to discuss, and reach agreement on, discrepancies [24, 27].
Results and discussion
Overview of included studies
An overview of included studies is offered in Table 3. An overview of excerpts from selected studies representing the formation of the narrative presented in the results and discussion section can be found as a table in supporting information (S1 Table. Forming the narrative–representative excerpts from selected studies). Data from the studies included in our results was most often collected using purely quantitative methods (N = 28), with some articles choosing to use mixed methods (N = 2) or qualitative methods (N = 3). Data collection varied widely between studies, with some studies addressing national populations, while others collected data at the hospital level or individual level. Of the studies addressing a specific illness (N = 18), approximately half of these addressed either HIV or blood/heart related illnesses. Of the technologies addressed by included studies, information/communication technologies (electronic health records and internet portals, e-health, internet-based social networks) and medical services technologies (prescription drugs, medical imaging, and diagnostic and treatment tools) dominated. Measurements of social position and inequality were relatively consistent with commonly used socio-economic variables, varying between income (or GDP in country comparisons), education, and employment status, in addition to geographical location, age, gender, and race/ethnicity. Outcome measures varied widely, however most studies were interested in investigating factors influencing the access, distribution, and/or use of specific technologies by various social groups (for example individual behaviors, facilitators and/or barriers). Some studies, however, addressed consequences associated with poor or limited access to these technologies, including related morbidity and/or mortality.
Addressing classification and measurement challenges: Towards a more precise terminology
All variables used in included studies to address, define and measure social position acknowledge that these variables represent various social groups, or classes, that live in relative advantage/disadvantage to one another. These variables can be divided into three distinct approaches. The first approach is characterized by a distinction between selected social groups based on fixed (or ascriptive) factors. These studies use age, gender and/or race/ethnicity to define and measure differences between social groups. The second approach is characterized by social position determining an individual’s control of various flexible resources that are to a relative degree amendable . These studies generally stratify social position based on socio-economic variables such as education, income, and insurance or employment status. Unlike the two aforementioned approaches, the third approach is distinguished by the characteristics of place . These studies use geographic location as a measure of social stratification, often defined as (but not limited to) a distinction between rural and urban settings.
These distinct approaches are similarly used to investigate social inequalities, however it is possible to question whether these distinct approaches can be used interchangeably to understand variations in the distribution of population health and innovative health technologies. Although SES may, for example, include various measures such as education, income, and occupational status, used alone or in combinations, one could question whether the mechanisms connecting education to health and technology are the same as the mechanisms connecting occupation or insurance status to health and technology. In relevant literature, such reflections are by and large missing, and very different measures of social position are often treated and interpreted similarly, which may affect the applicability and usability of results . The implications of choosing one approach over another may have consequences on both theoretical and practical understandings of the specific social factors that influence access and use of innovative health technologies. In the studies included in our analysis, it is possible to observe variations in measured inequality based on chosen variables. The variation in results from these studies illustrate that whether or not inequalities in access and use of innovative health technologies are observable are dependent on the approach used to measure these inequalities and that common measures of social inequality in health cannot be used uncritically.
Our findings, however, may suggest that variations in measurement techniques are, in part, rooted in cultural or scientific traditions. It is interesting to note, for example, that although many of the studies from North America and Australia used a variety of approaches to measuring social inequality, race/ethnicity was often included. Race/ethnicity was, however, never included as a variable in collected studies originating from European, Asian, or South American countries, which instead favored the use of various measures of socio-economic status, such as income or education. Our results do not provide a clear explanation to this finding, but one may question whether this is due purely to availability of data or to cultural and historical factors, where race and ethnicity are more strongly associated with social stratification and class positions in North America and Australia [31, 32]. Regardless, the previous findings raise important questions regarding the extent to which social inequalities in access and use of innovative health technologies are dependent on the approach used to measure and define social groups, which must be critically addressed in future research.
Innovative health technologies.
Although it is possible to broadly categorize technologies in included studies by type, a potentially more informative method of categorizing these technologies from a social inequalities in health context is by variations in access and use. Using an approach similar to those presented by Cotterman and Kumar , and a focus on level of perceived end-user control, it is possible to propose a division of technologies into three main categories (see Fig 3): technologies accessed and used directly by the end user (type 1 or direct end-user technologies), technologies used by the end user but accessed through someone other than the end user (type 2, or direct-use gatekeeper technologies), and technologies accessed and used by someone other than the end user (type 3, or indirect-use gatekeeper technologies). In this case “end user” is defined as the individual, or group of individuals, for which the technology is developed. End users generally do not include individuals who develop, operate, or distribute these technologies, unless these individuals are also end users (the operator of a direct end-user technology, for example, is also the end user). As the name implies, “gatekeepers,” in this case, are individuals that guard access and eventual use of technologies by end users .
In the case of indirect-use gatekeeper technologies (type 3) and direct-use gatekeeper technologies (type 2), end-users are dependent on gatekeepers in order to gain access to these technologies. Korda et al. , for example, investigated the use of a number of coronary procedure technologies dependent on the expertise of health care personnel in which end users have very little direct control over the use and administration of these types of technologies [20, 34]. The technology examined by Rubin et al.  (highly-active antiretroviral therapy) differed in that, although access is dependent on a physician, use of the technology is significantly dependent on behavior by the end-user. Results by both Korda et al.  and Rubin et al.  demonstrate that, after the initial adoption of these technologies, social inequalities in health grew, regardless of whether the use of these technologies was dependent on end user behavior and, furthermore, regardless of the fact that these technologies must be accessed by way of trained health personnel. Results by Korda et al.  however also suggest that these inequalities may decline over time, as the adoption by lower SES groups increases.
“The SES inequalities in diffusion observed for angiography and CABG are consistent with the lag in diffusion/inverse inequality hypothesis–for both these procedures, rates peaked earlier in the higher SES patients than the lower SES patients resulting in inequalities, which then disappeared over time…”[20, 36]
Similar findings are corroborated by He et al. , Ohl et al. , and Stanley et al. . Moreover, results by Goldman and Lakdawalla  demonstrate that complicated treatment regimens increase social inequalities in health while simplifying treatment regimens reduce inequalities, illustrating the dynamic complexity of the relationship between access and use of innovative technologies and variations in social inequalities in health.
“Simply by improving the productivity of healthcare, new technologies can widen disparities across socioeconomic groups. However, new treatments that simplify the production of health and reduce the importance of patient effort work in the opposite direction…complex new treatments for HIV appear to have increased disparities among HIV+ individuals, while pharmaceutical breakthroughs in the treatment of hypertension made self-management less important and coincided with a contraction in disparities…”
Nevertheless, the results highlighted above suggest that SES influences variations in the use of innovative technologies by end users even when access is dependent on a “gatekeeper”.
Direct end-user technologies (type 1), contrary to direct-use gatekeeper (type 2) and indirect-use gatekeeper technologies (type 3), are directly accessed and used by end users. The access and use of these technologies is assumed largely dependent on individual agency, or in other words, the assumption that individuals are equally able to consciously make decisions to access or use these technologies for purposes of influencing health. However, the studies included in our results consistently demonstrated that access and use of these technologies was far from equal. Baum et al. , for example, demonstrated that low socio-economic groups have restricted access and use of digital information and communication technologies that, in turn, affect access to a range of social determinants of health, creating a vicious cycle of disadvantage and poorer health.
“The educational opportunities to acquire fundamental literacy also shape health literacy, which therefore in turn affects people's ability to improve their health status and health outcomes. This disadvantage is compounded because digital literacy is increasingly a pre-requisite for health service delivery and access to health information.”
Gonzales et al.  indicate that access to technologies for disadvantaged groups is unstable, and can be regularly disrupted, suggesting that simply measuring access to technology adoption across socioeconomic groups ignores the possibility that unstable access–or unequal use–can have large consequences on social inequalities in health. Perez et al.  support these results, further demonstrating that purely having access to a particular technology does not guarantee equal use. In fact, an increase in social inequalities in health after the implementation of health technologies is often demonstrated by studies included in our results. Importantly, regardless of findings suggesting that these inequalities will decrease as access to these resources becomes more universal, results from included studies illustrate that access to resources does not necessarily eliminate the (re)production of social inequalities in health.
Unfortunately, our results do not clearly illustrate whether any one of the categories of technologies highlighted in included studies has the potential to influence social inequalities in health to a greater degree than another. Our findings do, however, illustrate a complex relationship, suggesting that the pathways and mechanisms through which inequalities increase or decrease over time vary depending on the factors that influence both access and use, as well as type, of these technologies. Furthermore, it was rare for studies included in our results to explicitly measure health outcomes related to the access or use of these technologies. Therefore, studies rarely addressed or investigated specific mechanisms or pathways linking health technology access and/or use to unique explanations of variations in health. Consequently, it is clear that more research is needed to further understand these complex mechanisms.
It is also clear that some important technologies are missing from the literature. The technologies addressed by studies included in our results focus predominantly on technologies designed and used in health care services. Included in this collection of technologies is a growing focus on the internet and internet-based tools, as the use of these technologies also become an integrated resource in health care services [3, 4, 42, 44–46]. However, as various researchers have highlighted in recent years, technologies that have the potential to greatly influence health and social inequalities in health are not limited to those found in health care services [3, 6, 7, 11]. These technologies include innovations used to monitor and control individual health, such as genome sequencing and lifestyle technologies (wearable devices and personal, digital applications, for example). It is, therefore, clear that future research investigate the potential implications of these types of innovative technologies on social inequalities in health.
Discussing potential pathways: Conceptualizing access and use
The studies included in this article exhibit varying approaches for conceptualizing the relationship between innovative health technologies and social inequalities in health. Studies discussing a perspective grounded in individual access and adoption of these technologies [18, 20, 39, 47–49] often refer to the diffusion of innovations theory, which categorizes adopters of innovations based on individual characteristics related to social positioning . These studies use this theory to establish that lower SES groups are slowest to adopt, and therefore benefit less from, innovative health technologies. However, as access to these technologies “diffuses” throughout the population, and lower SES groups begin to adopt, these inequalities begin to diminish and may potentially disappear [18, 20, 37–40, 47].
“Income gradients were positive in an era prior to statins, but became negative in the period subsequent to the advent and dissemination of statins. While the more advantaged were once more likely to have high levels of cholesterol and LDL, they are now definitively less likely. Additionally, exploratory analyses suggest that income is positively associated with statin use accounting for clinical need… While resources affect access to technologies, some technologies can also affect resources, lessening the productivity of various health inputs.”
Although this perspective assumes that the unequal adoption of these technologies is relatively unavoidable, they argue that the extent to which these innovations influence social inequalities in health is subject to the rate at which these technologies diffuse.
Building on this explanation, a number of studies [18, 19, 35, 47, 50] draw attention to the fundamental cause theory, which suggests that individuals “deploy” flexible resources, “such as money, knowledge, power, prestige, and beneficial social connections…to avoid risks and adopt protective strategies” . These studies use this theory to illustrate that innovative health technologies are accessed to a greater degree by individuals of higher social position.
“The SES–HIV/AIDS mortality association, although present in the pre HAART period, was greater in the peri-HAART period and greater still in the post HAART period, even when race and other factors were controlled…These findings are consistent with fundamental cause theory, which holds that when innovations render a disease more treatable, the benefits of such developments are not evenly distributed.”
Explanations referring to the fundamental cause theory and the diffusion of innovations, however, often assume that as innovative health technologies become more evenly distributed–or adopted–across social strata, so too will their benefits.
The above perspectives are contrasted by studies presenting social inequalities more specifically as a consequence of variations in use of innovative health technologies. These discussions often refer to explanations grounded in theories related to health literacy [43, 44, 51, 52] or digital divide [41, 42, 46, 53–55]. While health literacy refers to an individual’s ability to assess, understand, and use information critical to using health services and making decisions regarding health , digital divide refers to variations in the use of digital technologies between social strata . These studies suggest that, regardless of access, inequalities exist due to the characteristics of social position determining an individual’s proficiency in using innovative health technologies to benefit health. Perez et al. , for example, demonstrate that, regardless of access to internet-based tools, health information searching and processing strategies vary by SES, benefitting higher educated individuals.
“When confronted with a specific set of symptoms, higher-SES participants tended to use search strategies that branch out—the exploration of conditions they expect contribute to the symptoms and systematically exploring offshoots of that condition, such as related conditions or symptoms. Lower-SES participants used heuristics to prune the scope of their Internet search—i.e., heuristics to ignore or remove search topics believed to be superfluous to the condition.”
Results by Zibrik et al.  and Newman et al.  illustrate the significance of socioeconomic and cultural factors influencing variations in the quality of use of innovative health technologies, favoring individuals of higher social position. These studies emphasize the experiences of individuals with innovative health technologies, demonstrating that variations in user experience as a result of social positioning has the potential to undermine the benefits assumed by universal access.
The above theories, however, seem to suggest that these inequalities are driven by the potential of social positioning to provide individuals with the ability to make conscious choices and “consume” these resources , assuming that these choices are made consciously and with motivated intent to improve health . However, numerous studies included in our results highlight the importance of mechanisms at the institutional and political levels that may significantly influence the distribution, in access and use, of innovative health technologies across social strata [14, 34, 37, 45, 57–64]. Many of these studies demonstrate that patterns of adoption and use of innovative health technologies at the level of the health care institution may significantly influence the potential of these innovations to benefit the health of end users regardless of individual choice or intent.
“Patients admitted to non-minority-serving hospitals were more likely to receive carotid artery imaging than patients admitted to minority-serving hospitals…the predicted probabilities of receiving carotid artery imaging were similar between white patients and black patients at non-minority-serving hospitals…However, the predicted probabilities among white patients and black patients at minority-serving hospitals were both significantly lower than white patients at non-minority-serving hospitals.”
Furthermore, a study by Lang and Mertes  demonstrated that the prevailing orientation of dominating political parties can influence how innovative health technologies are accessed and used at the State level, resulting in variations in the distribution of these resources. In a similar discussion, Han et al.  refer explicitly to the social determinants of health theory, which describes the unequal distribution of health as a result of socioeconomic conditions that are largely constructed by social policy , to stress the significance of a geographical patterning of health influencing variations in access and use of innovative health technologies.
Due to a focus on single technologies, however, many of the perspectives discussed above fail to address the potential influence that the rapid, uninterrupted development of new technologies may have on the reduction or (re)production of social inequalities in health. It could be suggested that the cumulative effects of multiple technologies adopted over time is itself a mechanism for (re)producing health disparities. In this case, potential mechanisms could be related to windfall benefits , which are benefits afforded by early adopters (high SES individuals) that accumulate over time, or Bourdieu’s theories of capital and symbolic violence , where the development and implementation of innovative technologies by high SES groups may reinforce social stratification. Baum et al.  demonstrate that Bourdieu’s social theories are a relevant addition to a discussion of innovative health technologies and social inequalities in health, drawing attention to the ways that innovative health technologies potentially influence the interaction of social, cultural, and economic capital to reproduce inequalities in health. They conclude that “some people are being caught in a vicious cycle whereby the inability to make beneficial use [of innovative health technologies] reinforces and amplifies existing disadvantage” .
The results of this study, therefore, seem to suggest that understanding the pathways through which various innovative health technologies reduce or (re)produce social inequalities in health is context dependent. Theories focused on the dependency of individual resources, such as fundamental cause theory, may therefore be most appropriate for understanding socially stratified variations in the access and use of direct end-user (type 1) technologies. Interestingly enough however, studies referring to these theories generally address direct and indirect-use gatekeeper (types 2 and 3) technologies, allowing one to question the merit of these explanations. Conversely, mechanisms at the institutional and political levels would thus seem most appropriate in explaining direct and indirect-use gatekeeper (types 2 and 3) technologies, where the advantages of these technologies are often poorly recognized by individuals of lower social status or where access is limited by gatekeepers (for example, political or institutional agents). In order to better understand social inequalities in health, these contextual variations draw attention to the need for critical distinctions between technologies based on how, and in what context, these various technologies are accessed and used. This may include a stronger focus on understanding the role of institutions and accompanying theories that explain complex mechanisms influencing the distribution of population health .
Some limitations not addressed earlier in this study are worth discussing. First, although the choice of search terms was purposefully broad and systematically identified using relevant literature, it is possible that the ability to collect relevant literature from a larger breadth of research fields and traditions could have been limited. This is due to the possibility that the researchers’ previous relation to the fields of sociology and health limit the familiarity, and therefore inclusion, of relevant terms or language used in the fields of technology and innovation. Second, the decision to exclude grey literature, including books, reports, etc., may have led to the exclusion of relevant literature, which could have possibly been used to widen or further support perspectives presented in the results. However, this choice was made with consideration for a purposeful selection of empirical, peer-reviewed studies using original data analyses. The goal here was to increase the probabilities of including relatively high quality research and excluding the possibility of grey material that is lower in quality and neither peer-reviewed nor includes original analyses. Furthermore, as grey literature includes reports and documents often drafted by order of political or special interest organizations, it is more difficult to assess underlying biases that would negatively bias our results. Third, the decision to exclude studies focused on treatment techniques within health services may have excluded some relevant literature. Very often, treatment techniques are dependent on the use of a specific technology. However, had the current study included literature focused on treatment techniques, without a specific focus on the technology used in this treatment, it would have been up to the authors to investigate whether or not each treatment technique included the use of an innovative technology, introducing bias as well as a very problematic assessment process. Furthermore, the inclusion of such studies would have shifted the focus of the current study from that of one focused on novel perspectives related to technology and public health to one focused on the relatively well established field of social inequalities in treatment and health services. The authors, therefore, felt that the inclusion of such studies was out of the scope of the current study and would have fundamentally transformed the current study’s aims and contribution to the scientific literature.
This review was interested in systematically investigating existing literature that explores the influence of innovative technologies on social inequalities in health. The results of this study offer interesting perspectives worth consideration, with implications for further investigation of the influence of innovative health technologies on social inequalities in health. This study questions established scientific measures of social inequality, where various measurements (such as race/ethnicity, income, education, geography, etc.) are often used interchangeably to investigate variations in access and use of innovative health technologies. Results illustrate that the choice of measurement has the potential to bias findings and, therefore, significantly influence the understanding of complex relationships between innovative health technologies and social inequalities in health. Furthermore, this study proposes that a social inequalities perspective may benefit from an understanding, and differentiation, of technologies based on how these technologies are accessed and used by end users. Factors and mechanisms that influence access, for example, may differ from factors and mechanisms that influence use. It is clear that it is not enough to solely focus on the factors and mechanisms that influence unequal access and therefore ignore how variations in use importantly shape social inequalities in health. It is, moreover, not enough to focus attention solely on health care services technologies but, importantly, to investigate emerging technologies in lifestyle health, genomics, and the increased use of personalized devices in health. Furthermore, a deeper understanding of social inequalities in health and innovative health technologies is dependent on distinguishing between a perspective focused on individual resource use, which often draws a questionable causal relationships between SES, technology access/use, and health outcomes, and a perspective focused on mechanisms that are more dependent on social and institutional structure than on individual agency. Although the studies included in our results generally suggest that the implementation and adoption of new technologies (re)produce SES and class-based social inequalities in health, some results indicate that these technologies can, in fact, reduce inequalities over time. Additional research, based on the findings discussed in this study, are needed, however, to reliably establish these conclusions. As much of the current research is dominated by the use of quantitative methods of social epidemiology, additional research may benefit from an increased use of qualitative, sociological methods in order to further investigate mechanisms and pathways leading to the (re)production of social inequalities in health as a result of innovative technologies [8, 30]. It is, nevertheless, becoming increasingly important to investigate the social implications and consequences of a society increasingly influenced by technological innovations, including the ways in which these technologies may influence the unequal distribution of health as a human right.
S1 Table. Forming the narrative–representative excerpts from selected studies.
- 1. Beckfield J, Bambra C, Eikemo TA, Huijts T, McNamara C and Wendt C. An institutional theory of welfare state effects on the distribution of population health. Social Theory & Health 2015: 227–244.
- 2. Mackenbach JP. The persistence of health inequalities in modern welfare states: the explanation of a paradox. Soc Sci Med 2012; 75: 761–769. pmid:22475407
- 3. Piot P. Innovation and technology for global public health. Global public health 2012; 7: S46–S53. pmid:22780442
- 4. Casper MJ and Morrison DR. Medical sociology and technology critical engagements. J Health Soc Behav 2010; 51: S120–S132. pmid:20943577
- 5. Cockerham WC. Health Lifestyle Theory and the Convergence of Agency and Structure*. J Health Soc Behav 2005; 46: 51–67. pmid:15869120
- 6. Lupton D. The quantified self. John Wiley & Sons, 2016.
- 7. Swan M. Emerging patient-driven health care models: an examination of health social networks, consumer personalized medicine and quantified self-tracking. Int J Environ Res Public Health 2009; 6: 492–525. pmid:19440396
- 8. McGibbon E and Peter E. An Ethnography of Everyday Caring for the Living, the Dying, and the Dead Toward a Biomedical Technography. Qualitative Inquiry 2008; 14: 1134–1156.
- 9. Link BG. Epidemiological sociology and the social shaping of population health. J Health Soc Behav 2008; 49: 367–384. pmid:19181044
- 10. Lupton D. Health promotion in the digital era: a critical commentary. Health Promot Int 2015; 30: 174–183. pmid:25320120
- 11. Tuckson RV, Newcomer L and De Sa JM. Accessing genomic medicine: affordability, diffusion, and disparities. JAMA 2013; 309: 1469–1470. pmid:23571584
- 12. Barclay G, Sabina A and Graham G. Population health and technology: Placing people first. Am J Public Health 2014; 104: 2246–2247. pmid:25320892
- 13. Rogers EM. Diffusion of Innovations. Free Press, New York, 2003.
- 14. Woolf SH, Johnson RE, Phillips RL Jr and Philipsen M. Giving everyone the health of the educated: An examination of whether social change would save more lives than medical advances. Am J Public Health 2007; 97: 679–683. Article. pmid:17329654
- 15. Phelan JC and Link BG. Fundamental cause theory. Medical sociology on the move. Springer, 2013, pp.105–125.
- 16. Fong H and Harris E. Technology, innovation and health equity. Bull World Health Organ 2015; 93: 438–438. pmid:26170497
- 17. Wise PH. Emerging technologies and their impact on disability. The Future of Children 2012; 22: 169–191. pmid:22550690
- 18. Chang VW and Lauderdale DS. Fundamental Cause Theory, Technological Innovation, and Health Disparities: The Case of Cholesterol in the Era of Statins. J Health Soc Behav 2009; 50: 245–260. Article; Proceedings Paper. pmid:19711804
- 19. Glied S and Lleras-Muney A. Technological innovation and inequality in health. Demography 2008; 45: 741–761. pmid:18939670
- 20. Korda RJ, Clements MS and Dixon J. Socioeconomic inequalities in the diffusion of health technology: Uptake of coronary procedures as an example. Soc Sci Med 2011; 72: 224–229. pmid:21147510
- 21. Phelan JC, Link BG, Diez-Roux A, Kawachi I and Levin B. “Fundamental causes” of social inequalities in mortality: a test of the theory. J Health Soc Behav 2004; 45: 265–285. pmid:15595507
- 22. Lutfey K and Freese J. Toward some fundamentals of fundamental causality: socioeconomic status and health in the routine clinic visit for diabetes1. American Journal of Sociology 2005; 110: 1326–1372.
- 23. Freese J and Lutfey K. Fundamental causality: challenges of an animating concept for medical sociology. Handbook of the sociology of health, illness, and healing. Springer, 2011, pp.67–81.
- 24. Pham MT, Rajić A, Greig JD, Sargeant JM, Papadopoulos A and McEwen SA. A scoping review of scoping reviews: advancing the approach and enhancing the consistency. Research synthesis methods 2014; 5: 371–385. pmid:26052958
- 25. Armstrong R, Hall BJ, Doyle J and Waters E. ‘Scoping the scope’of a cochrane review. Journal of Public Health 2011; 33: 147–150. pmid:21345890
- 26. Shankardass K, Solar O, Murphy K, Greaves L and O’Campo P. A scoping review of intersectoral action for health equity involving governments. International Journal of Public Health 2012; 57: 25–33. pmid:21931976
- 27. Levac D, Colquhoun H and O'Brien KK. Scoping studies: advancing the methodology. Implementation Science 2010; 5: 1.
- 28. Arksey H and O'Malley L. Scoping studies: towards a methodological framework. International journal of social research methodology 2005; 8: 19–32.
- 29. Kawachi I, Subramanian S and Almeida-Filho N. A glossary for health inequalities. J Epidemiol Community Health 2002; 56: 647–652. pmid:12177079
- 30. Øversveen E, Rydland HT, Bambra C and Eikemo TA. Rethinking the relationship between socio-economic status and health: Making the case for sociological theory in health inequality research. Scandinavian Journal of Public Health 2017: 1403494816686711.
- 31. Gibbons MC, Fleisher L, Slamon RE, Bass S, Kandadai V and Beck JR. Exploring the potential of Web 2.0 to address health disparities. Journal of Health Communication 2011; 16: 77–89. pmid:21843097
- 32. Williams DR. Race/ethnicity and socioeconomic status: measurement and methodological issues. Int J Health Serv 1996; 26: 483–505. pmid:8840198
- 33. Cotterman WW and Kumar K. User cube: a taxonomy of end users. Communications of the ACM 1989; 32: 1313–1320.
- 34. Cheng EM, Keyhani S, Ofner S, Williams LS, Hebert PL, Ordin DL, et al. Lower use of carotid artery imaging at minority-serving hospitals. Neurology 2012; 79: 138–144. pmid:22700815
- 35. Rubin MS, Colen CG and Link BG. Examination of inequalities in HIV/AIDS mortality in the United States from a fundamental cause perspective.[Erratum appears in Am J Public Health. 2011 Jan;101(1):5]. Am J Public Health 2010; 100: 1053–1059. Research Support, Non-U.S. Gov't. pmid:20403885
- 36. Korda RJ, Clements MS and Dixon J. Socioeconomic inequalities in the diffusion of health technology: Uptake of coronary procedures as an example. Soc Sci Med 2011; 72: 224–229. pmid:21147510
- 37. He D, Yu H and Chen YY. Equity in the distribution of CT and MRI in China: a panel analysis. Int J Equity Health 2013; 12: 15. Article.
- 38. Ohl M, Lund B, Belperio PS, Goetz MB, Rimland D, Richardson K, et al. Rural residence and adoption of a novel HIV therapy in a national, equal-access healthcare system. AIDS Behav 2013; 17: 250–259. Article. pmid:22205324
- 39. Stanley A, DeLia D and Cantor JC. Racial disparity and technology diffusion: the case of cardioverter defibrillator implants, 1996–2001. J Natl Med Assoc 2007; 99: 201–207. Comparative Study Research Support, Non-U.S. Gov't. pmid:17393943
- 40. Goldman DP and Lakdawalla DN. A theory of health disparities and medical technology. Contributions in Economic Analysis & Policy 2005; 4.
- 41. Baum F, Newman L and Biedrzycki K. Vicious cycles: digital technologies and determinants of health in Australia. Health promotion international 2014; 29: 349–360. pmid:23144236
- 42. Gonzales AL, Ems L and Suri VR. Cell phone disconnection disrupts access to healthcare and health resources: A technology maintenance perspective. New Media Soc 2016; 18: 1422–1438. Article.
- 43. Perez SL, Kravitz RL, Bell RA, Chan MS and Paterniti DA. Characterizing internet health information seeking strategies by socioeconomic status: a mixed methods approach. BMC Med Inform Decis Mak 2016; 16: 9. Article.
- 44. Goel MS, Brown TL, Williams A, Hasnain-Wynia R, Thompson JA and Baker DW. Disparities in enrollment and use of an electronic patient portal. J Gen Intern Med 2011; 26: 1112–1116. pmid:21538166
- 45. Hing E and Burt CW. Are there patient disparities when electronic health records are adopted? J Health Care Poor Underserved 2009; 20: 473–488. Article. pmid:19395843
- 46. Newhouse N, Lupianez-Villanueva F, Codagnone C and Atherton H. Patient Use of Email for Health Care Communication Purposes Across 14 European Countries: An Analysis of Users According to Demographic and Health-Related Factors. J Med Internet Res 2015; 17: 11. Article. pmid:25798912
- 47. Ferris TG, Kuhlthau K, Ausiello J, Perrin J and Kahn R. Are minority children the last to benefit from a new technology? Technology diffusion and inhaled corticosteriods for asthma. Med Care 2006; 44: 81–86. pmid:16365616
- 48. Slade EP and Anderson GF. The relationship between per capita income and diffusion of medical technologies. Health Policy 2001; 58: 1–14. Comparative Study Research Support, Non-U.S. Gov't. pmid:11518598
- 49. Wang PJ, Chou YJ, Lee CH and Pu C. Diffusion of new medication across different income groups under a universal health insurance program: An example involving newly enlisted nonsteroidal anti-inflammatory drugs for elderly osteoarthritis patients. Int J Public Health 2010; 55: 497–506. Article. pmid:20237818
- 50. Polonijo AN and Carpiano RM. Social inequalities in adolescent human papillomavirus (HPV) vaccination: A test of fundamental cause theory. Soc Sci Med 2013; 82: 115–125. Article. pmid:23337830
- 51. Choi NG and DiNitto DM. The Digital Divide Among Low-Income Homebound Older Adults: Internet Use Patterns, eHealth Literacy, and Attitudes Toward Computer/Internet Use. J Med Internet Res 2013; 15: 16. Article. pmid:23639979
- 52. Zibrik L, Khan S, Bangar N, Stacy E, Lauscher HN and Ho K. Patient and community centered eHealth: Exploring eHealth barriers and facilitators for chronic disease self-management within British Columbia's immigrant Chinese and Punjabi seniors. Health Policy Technol 2015; 4: 348–356. Article.
- 53. Eddens KS, Kreuter MW, Morgan JC, Beatty KE, Jasim SA, Garibay L, et al. Disparities by Race and Ethnicity in Cancer Survivor Stories Available on the Web. J Med Internet Res 2009; 11: 11. Article. pmid:19945948
- 54. Kontos EZ, Emmons KM, Puleo E and Viswanath K. Communication inequalities and public health implications of adult social networking site use in the United States. Journal of health communication 2010; 15: 216–235. pmid:21154095
- 55. Newman L, Biedrzycki K and Baum F. Digital technology use among disadvantaged Australians: implications for equitable consumer participation in digitally-mediated communication and information exchange with health services. Aust Health Rev 2012; 36: 125–129. Article. pmid:22624630
- 56. Lupton D. The digitally engaged patient: Self-monitoring and self-care in the digital health era. Social Theory & Health 2013; 11: 256–270.
- 57. Bekelis K, Missios S and Labropoulos N. Regional intensity of neurosurgical care and integration of aneurysm coiling in the United States. Int Angiol 2014; 33: 446–454. Article. pmid:25294286
- 58. Butler MJ, Harootunian G and Johnson WG. Are low income patients receiving the benefits of electronic health records? A statewide survey. Health Informatics J 2013; 19: 91–100. Review. pmid:23715209
- 59. Groeneveld PW, Laufer SB and Garber AM. Technology diffusion, hospital variation, and racial disparities among elderly Medicare beneficiaries 1989–2000. Med Care 2005; 43: 320–329. Article.
- 60. Han JH, Sunderland N, Kendall E, Gudes O and Henniker G. Professional practice and innovation: Chronic disease, geographic location and socioeconomic disadvantage as obstacles to equitable access to e-health. Health Inf Manag J 2010; 39: 30–36. Review.
- 61. Horvitz-Lennon M, Alegría M and Normand SLT. The effect of race-ethnicity and geography on adoption of innovations in the treatment of schizophrenia. Psychiatr Serv 2012; 63: 1171–1177. Article. pmid:23026838
- 62. Lang A and Mertes A. e-Health policy and deployment activities in Europe. Telemed J E Health 2011; 17: 262–268. Article. pmid:21476924
- 63. Loureiro S, Simões B, Aragão E, Mota F, Moura H and Damasceno L. Diffusion of medical technology and equity in health in brazil: an exploratory analysis. The European Journal of Development Research 2007; 19: 66–80.
- 64. Ohlsson H, Chaix B and Merlo J. Therapeutic traditions, patient socioeconomic characteristics and physicians' early new drug prescribing-a multilevel analysis of rosuvastatin prescription in south Sweden. Eur J Clin Pharmacol 2009; 65: 141–150. Article. pmid:18836707
- 65. Marmot M and Wilkinson R. Social determinants of health. Oxford University Press, 2005.
- 66. Grenfell MJ. Pierre Bourdieu: key concepts. Routledge, 2014.